Why 2017 Was a Year to Remember for Exact Sciences Corporation
Any year that a stock goes up 40% would count as a memorable year. But what about a year where a stock soars nearly 340%? That's what has happened for Exact Sciences Corporation (NASDAQ: EXAS) in 2017 -- and there are still a few weeks left to go in the year.
To say that 2017 will be a year to remember for Exact Sciences is an understatement. Here's how the molecular diagnostics company achieved its tremendous success and whether that success is likely to continue into 2018.
Source: Fool.com